Tumor hypoxia, a hallmark of solid tumors, drives aggressive behavior and therapeutic resistance through stabilization of hypoxia-inducible factor 1-alpha (HIF1α), which regulates genes involved in angiogenesis, metabolism, and immune evasion [10,11]. The gene discussed is HIF1A; the disease is neoplasm.